Established markers of Treg functionality are lacking, however polymorphisms in Tregs effector genes such as CTLA-4, GITR, FoxP3 have been linked to susceptibility to autoimmune diseases in humans, including MS [11], [12]. The gene discussed is CTLA4; the disease is myeloid sarcoma.